Prevention & care

Mononucleosis: glandular fever, EBV, antibody tests, fatigue, steroids, and spleen precautions

6 sources · Latest source check 2026-10-13 UTC

On this page

Infectious mononucleosis, often called mono or glandular fever, is an illness most commonly caused by Epstein–Barr virus, or EBV. Other infections can produce a similar syndrome. EBV infection and symptomatic mono are not identical: many people acquire EBV without developing the recognizable illness.[1][2]

Virus, syndrome and test marker are different

Virus, syndrome and test marker are different
Term	Meaning
EBV	A herpes-family virus that can remain latent after infection.[2]
Mono / glandular fever	A clinical illness commonly associated with EBV.[1]
Monospot	A heterophile-antibody test; it does not specifically confirm EBV.[3]

Saliva exposure can occur before a recognizable illness

EBV commonly spreads through saliva, including kissing or shared items contaminated with saliva. Shedding can occur before symptoms and after recovery; reactivation can allow later transmission. A date of symptom onset cannot establish exactly when an infection was acquired. Avoiding shared drinks or toothbrushes reduces relevant exposure opportunities.[2]

A prolonged recovery is possible without one universal timetable

Fever, sore throat, swollen lymph nodes and marked fatigue are typical. The liver or spleen can enlarge. CDC describes usual improvement within two to four weeks, with fatigue sometimes lasting much longer. Recovery varies, and persisting or changing symptoms need assessment rather than an assumption that all fatigue has one cause.[1]

The pattern of antibodies matters more than a single positive

CDC distinguishes antibodies to viral capsid antigen from EBV nuclear antigen. Some antibodies appear early; others develop later and can persist. Past infection is common, so an isolated positive antibody result is not a diagnosis of current mono. Timing and clinical information are required to interpret the pattern.[3]

CDC does not recommend Monospot for general use: false positives and false negatives occur, and children may not develop the antibodies it measures. A compatible illness may require a different testing approach. No single home interpretation establishes EBV as the cause of persistent symptoms.[3]

Supportive care and treatment of complications serve different purposes

NHS describes rest, fluids and suitable pain or fever relief. Antibiotics do not treat the viral illness. A clinician may investigate other causes of a severe sore throat or manage a complication; that is a different question from prescribing an antibiotic for EBV itself. Medicine suitability still depends on age and other circumstances.[4]

A short-term sore-throat signal does not establish routine benefit

A Cochrane review with evidence through August 2015 included seven trials and 362 participants. Some findings suggested short-term sore-throat relief, but other symptom effects were unclear. Trials varied in medicines, combinations and follow-up; overall study quality was poor, and adverse-effect evidence was limited.[5]

These findings do not establish that everyone with mono should receive steroids or that transient relief improves long-term recovery. Clinicians may face separate severe-complication decisions. The review’s age, small studies and weak safety assessment remain visible rather than being converted into a confident universal treatment rule.[5]

Feeling less tired does not prove sports are safe

An enlarged spleen can remain a concern after fatigue improves. CDC warns against contact sports because of rupture risk, and NHS also cautions about strenuous activity or lifting. Return to those activities needs clinical guidance rather than a symptom-only calendar. Severe abdominal pain, inability to swallow or severe breathing difficulty needs urgent local medical care.[1][4]

A past infection is not an explanation for every future symptom

NHS describes prolonged fatigue as a possible complication. Continuing fatigue still deserves attention to daily function and other explanations. This educational account does not label an individual as having chronic active EBV, determine infectiousness or supply a return-to-sport clearance.[4]

A return-to-sport timetable is conditional

AAFP describes avoiding athletic activity for three weeks from symptom onset, then considering light noncontact activity only when clinically well and without fever. Return requires shared assessment; the date alone is not clearance for collision sport. The recommendation draws on guidance and retrospective evidence about rare splenic injury rather than a randomized experiment guaranteeing safety at a fixed day.[6]

Evidence & uncertainty

Most recover with supportive care. Persistent fatigue and spleen precautions need separate attention. An antibody result does not alone prove new infection; evidence for routine steroid symptom relief remains uncertain.[4][3][5]

Selected-source overview · Independent review pending

Published questions

Does every Epstein Barr virus infection cause recognizable mononucleosis?

Selected-source overview · Independent review pending. Read the evidence context.

EBV infection can occur without the typical mono illness.[2]

Evidence behind this answer

About Epstein-Barr Virus
agency condition or prevention explanation · Date not stated
Selected relevant original official page passages inspected · Silent acquisition, latency, reactivation and saliva exposure